Remove 2019 Remove Financial Market Remove Portfolio
article thumbnail

MiB: Jon McAuliffe, the Voleon Group

The Big Picture

McAuliffe has a unique track record of successful innovation applying statistical methods to real-life prediction problems, particularly in the financial markets. We discuss his career in machine learning, from Amazon’s recommendation engine to using AI to manage portfolios.

article thumbnail

Cipla Vs Sun Pharmaceutical – Financials, Future Plans & More

Trade Brains

we shall also see their financials, future plans and more Cipla Vs Sun Pharmaceutical Cipla Company Overview Cipla was established in 1935 by Khwaja Abdul Hamied in Mumbai. The company’s portfolio includes complexes and drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and other key therapeutic fields.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Titagarh Railsystems vs Jupiter Wagons – Future Plans & More

Trade Brains

Particulars/ Financial Year Revenue (Cr.) 2019-20 ₹ 1,766.32 ₹ 125.74 2019-20 ₹ - 36.14 -₹ 0.13 Particulars/ Financial Year Debt to Equity Titagarh Railsystems Jupiter Wagons 2022-23 0.71 Particulars/ Financial Year Interest Coverage Titagarh Railsystems Jupiter Wagons 2022-23 3.24 2019-20 0.36 -0.48

Planning 105
article thumbnail

Adani Wilmar Vs Patanjali Foods – Financials, Future Plans & More

Trade Brains

Fortune, Kohinoor, Fryola, and Wilpuff are among the well-known brands in the company’s portfolio. Patanjali Foods Incorporated in 1986, Patanjali Foods (Formerly known as Ruchi Soya) is among the top FMCG players as a prominent manufacturer and marketer of a healthy range of edible oils and a pioneer of soya foods. 2020 29,766.98

Food 105
article thumbnail

Fundamental Analysis Of Waaree Renewable Technologies

Trade Brains

Financial Year Revenue (Cr.) 2019-20 5.68 -3.18 Financial Year OPM NPM 2022-23 23.86% 15.77% 2021-22 14.55% 5.50% 2020-21 53.85% -18.26% 2019-20 6.69% -55.99% 2018-19 45% -27.13% Average (5 Years) 28.79% -16% Return Ratios The company growth in RoE was 96.9% Financial Year Debt to Equity Interest Coverage 2022-23 0.46

article thumbnail

Fundamental Analysis Of Zydus Lifesciences – Financials & More Details

Trade Brains

From 2016 to 2019, the Indian pharmaceutical sector increased at a compound annual growth rate (CAGR) of 6.6%. The table below shows the leverage ratios of Zydus Lifesciences for 5 financial years: Year Debt to Equity Interest Coverage Ratios 2023 -0.03 From 2020 to 2030, it is expected to grow at a CAGR of 12.3%. during FY22.

article thumbnail

Fundamental Analysis of Talbros Automotive – Future Plans & More

Trade Brains

The following image depicts the customer base of Talbros Automotive across different OEM segments: Revenue Segment The Company, along with its joint venture companies, offers a diverse product portfolio that includes Gaskets, Heat Shields, Forgings, Chassis Systems, Suspension Systems, Anti-vibration Components, and Hoses. 2020 ₹ 385.29

Planning 105